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SUBCONJUNCTIVAL FRAGMENTATION  
OF A PREVIOUSLY EFFICIENT XEN GEL STENT 
IMPLANTATION AND SUCCESSFUL BLEB FORMATION:  
A CASE REPORT
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Department of Ophthalmology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia
SUMMARY – The XEN gel stent is one of the available minimally invasive glaucoma surgery 
devices, a new generation implant, which is designed to reduce intraocular pressure in patients with 
primary open angle glaucoma if past medical treatments have failed. This report presents a case of 
subconjunctival fragmentation of the XEN gel stent after a three-month follow-up of successful XEN 
gel implantation. A 70-year-old male patient was treated for primary open angle glaucoma. He under-
went successful phacoemulsification and intraocular lens implantation two years before. Due to med-
ical therapy failure in controlling glaucoma, XEN gel stent implantation was suggested to the patient. 
The implant was successfully placed in both eyes, and extended bleb and drainage aqueous humor 
from the anterior chamber to the subconjunctival space was obtained. Three months after the surgery, 
at a regular follow-up visit, three fragments of the subconjunctival part of the XEN gel implant were 
found in his left eye. Neither serious complications nor intraocular pressure increase were detected. A 
new potential complication of the XEN gel implant is described.
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Introduction
A novel technique of creating an alternative route 
through an ab interno approach via implantation of a 
collagen implant XEN (Allergan, Irvine, CA, USA) 
has been described in an attempt to overcome different 
complications that are seen in glaucoma filtration sur-
gery1,2. The XEN implant has been approved by the 
European Medicines Agency and the U.S. Food and 
Drug Administration for surgical treatment of glau-
coma. The XEN gel stent is a 6-mm hydrophilic tube 
with a 45-µm lumen size, composed of a porcine col-
lagen-derived gelatin crosslinked with glutaraldehyde. 
This gelatin stent provides ab interno approach and 
bypasses the natural drainage pathways, which often 
become obstructed and cause elevated intraocular 
pressure (IOP). The ideal stent placement should be 
2.0 mm of exposed implant in the subconjunctival 
space, 1.0 mm in the anterior chamber and 3.0 mm 
tunneled through the sclera. However, some cases of 
stent exposure have been described in the literature3, as 
well as dislocation of XEN gel into the anterior cham-
ber4, XEN gel internal ostium occlusion5, suprachoroi-
dal bleeding after XEN gel implantation6, and postop-
erative hypotony associated with a shallow anterior 
chamber and choroidal effusions after surgery7. As 
with all new devices, there is a lack of experience and 
knowledge about its long-term results in terms of ef-
ficacy, technique and complications8.
Case Report
This report presents a case of subconjunctival frag-
mentation of the XEN gel implant three months after 
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the surgery. Consent for publication of this case report 
was obtained from the patient. A 70-year-old male 
was treated and followed-up for primary open angle 
glaucoma in the Glaucoma Unit, Department of Oph-
thalmology, Sestre milosrdnice University Hospital 
Centre, Zagreb, Croatia. The patient underwent suc-
cessful phacoemulsification and intraocular lens im-
plantation two years before. Before surgery, the IOP 
was 26 mm Hg in the right eye and 24 mm Hg in the 
left eye despite maximum tolerated topical treatment 
with three IOP lowering medications (bimatoprost/
timolol fixed combination once in the evening and 
dorzolamide twice a day). Since IOP was poorly con-
trolled, XEN implantation was offered to the patient 
for both eyes, and the patient consented to the proce-
dure offered. Surgical steps for XEN implantation in 
both eyes included the following: 0.2 mg/mL of mito-
mycin C injected subconjunctivally in the area of 
planned XEN implantation, marking the conjunctiva 
3 mm from the limbus superonasally. The anterior 
chamber was filled with Healon GV (Abbot Medical 
Optics, Inc., Santa Ana, CA, USA) and inferotempo-
ral 1.8-mm clear corneal incision was created through 
which the preloaded inserter needle (double beveled 
27-gauge) was directed across the anterior chamber in 
the opposite side to penetrate the angle under gonio-
scopic view. Once the needle was visible in the subcon-
junctival space, it was rotated toward 12 o’clock and 
the stent was gently injected into the subconjunctival 
space. Healon GV was irrigated out of the anterior 
chamber at the end of surgical procedure. Intraopera-
tive mild intracameral hemorrhage occurred but it was 
promptly resolved with irrigation-aspiration proce-
dure. Due to overlong intrachamber part of the im-
plant, the blunt tweezer was used to relocate the im-
plant by scleral approach. The implant immediately 
began shunting fluid from the anterior chamber to the 
subconjunctival space with an initial extended bleb 
due to the gentle diffuse dispersion of aqueous humor 
into the non-dissected conjunctiva.
Postoperative treatment included a combination of 
dexamethasone and tobramycin administered 4 times 
daily for 15 days and then slowly reduced over the next 
2 weeks.
The surgery was successful in both eyes. Slit lamp 
examination confirmed proper positioning of the XEN 
implant and successful bleb formation. IOP was 14 
mm Hg in the right eye and 15 mm Hg in the left eye 
(with no IOP lowering medications) one and two 
months after the surgery.
Three months after the surgery, at the regular fol-
low-up visit, an uncommon adverse event was found. 
We noticed three fragments of the subconjunctival 
Fig. 1. Subconjunctival fragments of the XEN gel stent: 




Fig. 2. Gonioscopic view of the anterior chamber part of 
the XEN gel stent.
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part of the XEN gel in the patient’s left eye, as shown 
by slit-lamp and anterior segment optical coherence 
tomography (Fig. 1a and b). The IOP was 14 mm Hg 
despite the fact that there was no bleb formation in the 
area of previous XEN implantation. Gonioscopic view 
showed the intracameral part of the implant to be cor-
rectly located inside the Schlemm’s canal (Fig. 2).
Discussion and Conclusions
Our report suggests that subconjunctival fragmen-
tation of the XEN gel implant can occur after success-
ful placement and functional bleb formation. The im-
plant is a hydrophilic, non-inflammatory subconjunc-
tival gelatin stent. The gelatin stent swells and becomes 
soft when hydrated, which helps maintain its intended 
position as it adapts to the shape of the surrounding 
tissues to create permanent channel from the anterior 
chamber to the subconjunctival space9. This occurs 
within 2 minutes after implantation. Relocating the 
implant by scleral approach in case of short subcon-
junctival part (less than 2 mm) and long intracameral 
part (more than 1 mm) is an ordinary procedure dur-
ing surgery. The patient denied rubbing the eye or any 
other possible incident during those three months. For 
this reason, relocating the implant by scleral approach 
with blunt tweezers should not lead to the risk of stent 
fragmentation, especially because of its gelatinous 
properties.
However, this case report presents an uncommon 
adverse event detected at regular follow-up visit. In 
this case, after fragmentation of the XEN gel, the im-
plant does not utilize subconjunctival filtration for 
aqueous outflow. Subconjunctival filtration creates a 
non-physiologic route for aqueous outflow, which is 
the basis of traditional trabeculectomy and aqueous 
shunt glaucoma surgery5,6.
In conclusion, our report suggests a new potential 
complication of the XEN gel stent implantation. The 
mechanism of its occurrence remains unclear. At this 
moment, we are unaware of any report on subconjunc-
tival XEN gel fragmentation available in the literature. 
This could imply clinical significance of this case re-
port as the first report on the subconjunctival XEN gel 
fragmentation at three-month follow-up of successful 
and effective XEN gel implantation.
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Sažetak
SUBKONJUNKTIVNA FRAGMENTACIJA XEN GEL STENTA NAKON PRETHODNO  
USPJEŠNE IMPLANTACIJE I POSLJEDIČNOG FORMIRANJA FILTRACIJSKOG JASTUČIĆA:  
PRIKAZ SLUČAJA
K. Novak-Lauš, L. Knežević, G. Marić, M. Zorić-Geber i Z. Vatavuk
XEN gel stent je implantat nove generacije koji se rabi u minimalno invazivnoj kirurgiji glaukoma, namijenjen za sniža-
vanje intraokularnog tlaka u bolesnika s glaukomom primarno otvorenog kuta kada prethodno liječenje nije dovelo do želje-
nog rezultata. Prikazan je slučaj bolesnika kod kojega je nakon tri mjeseca praćenja uspješno implantiranog XEN gel stenta 
došlo do njegove subkonjunktivne fragmentacije. Muškarac u dobi od 70 godina liječen je zbog glaukoma otvorenog kuta. 
Dvije godine ranije imao je uspješnu operaciju katarakte s ugradnjom intraokularne leće. Zbog neuspješne kontrole glaukoma 
medikamentnom terapijom bolesniku je predložena implantacija XEN gel stenta. Implantat je uspješno implantiran u oba 
oka te je omogućen protok očne vodice iz prednje očne sobice u subkonjunktivni prostor uz formiranje filtracijskog jastučića. 
Tri mjeseca nakon operacije lijevoga oka, na redovnoj kontroli vizualizirana su tri fragmenta subkonjunktivnog dijela XEN 
gel stenta, bez da je prethodno bilo ozbiljnijih komplikacija ili porasta intraokularnoga tlaka. Opisana je nova moguća kom-
plikacija XEN gela implantata.
Ključne riječi: Intraokularni tlak; Glaukom otvorenog kuta; Leće, intraokularne, ugradnja; Stentovi; Minimalno invazivni 
kirurški postupci; Filtracijska kirurgija
